Skip to content
human IPSC-derived Cells
Company
Overview & Profile
Testimonials
Management & Team
Executive Board
Advisory Boards
Scientific Advisory Board
Axiogenesis Staff
Partners
Investor Relations
Contact Us
Science & Technology
Peer-reviewed Publications
Product Technology
Induced Pluripotent Stem Cells (iPS)
Embryonic Stem Cells (ES cells)
Drug Discovery
Services
Functional Cardiotox Services
Microelectrode Array (MEA)
Cor.4U Mel.Cor Human Cardiomyocyte MEA Assay Service
Cor.At Mel.Cor: Murine cardiomyocyte MEA assay service
XCelligence RTCA Cardio
CardioEffect Screening Service
Toxicology Services
µEST – In vitro Embryotoxicity Screening
Other Toxicology Services
Drug Development Services
Cardiomyopathy Screen
My.Cor Cardiomyopathy Screen
Customized Services
Products
Cardiac Cells
Cor.4U – Human iPS Cell-Derived Cardiomyocytes
vCor.4U – Human iPS Cell-Derived Ventricular Cardiomyocytes
FibroCor.4U – Human iPS Cell-Derived Cardiac Fibroblasts
Cor.At – iPS or ES Cell-Derived Mouse Cardiomyocytes
Neuronal Cells
Peri.4U – Human iPS Cell-Derived Peripheral Neurons
Dopa.4U – Human iPS Cell-Derived Dopaminergic Neurons
CNS.4U – Human iPS Cell-Derived Central Nervous
Astro.4U – Human iPS Cell-Derived Astrocytes
Other Cell Types
Smac.4M – ES Cell-Derived Mouse Smooth Muscle Cells
Assays
Electrophysiology
Manual Patch Clamp
Automated Patch Clamp
Microelectrode Array (MEA)
Calcium Sensitive/Voltage Sensitive Dyes
Label-free Analysis
Impedance Analysis
Cardiotoxicity
Cor.At Tox / Neutral Red Uptake (NRU) Assay
News
Advisory Boards
Michael Vogel – Chairman
Carl-Peter Gerlach – Vice-Chairman
Dr. Klaus Frobel
